Europe Faces Strategic Vulnerability as US Dominates Satellite and AI Infrastructure Warns Telecoms CEO US Consumer Resilience Factors Behind Rising Retail Spending Vickers Top Insider Picks Signal Potential Confidence for May 28 2026 Political Risk in UK Andy Burnhams Rise and the Churn in Establishment Power Dynamics Trumps Approval Rating Remains Below 39 in Latest Polls With More Declines Than Gains European Commission Fines Temu 200 Million Over Illegal and Dangerous Product Sales PHVS Q1 2026 Earnings NarrowerThanExpected Loss as Biotech Advances HAE Pipeline CMS Energy CMSD Q1 2026 Earnings Modest EPS Beat Amid Steady Utility Operations WIMI Q4 2020 Earnings EPS Misses Estimates Amid Slight Stock Decline IPAR Q1 2026 Earnings Strong EPS Beat Drives Stock Higher IX Q1 2026 Earnings EPS Misses Estimates as Operational Headwinds Persist Datasea Inc DTSS Q2 2022 Earnings Substantial EPS Miss as Stock Rises on Uncertain Outlook Yalla Group Limited YALA Holds Steady at 620 Amid Modest Gains Power Solutions International PSIX Edges Lower Consolidating Near Resistance at 45 Ocean Power Technologies OPTT Surges 7 as Renewables Momentum Builds Forgent Power Solutions Inc FPS Faces Resistance Slipping 128 Amid Cautious Trading CHS Inc CHSCO Holds at 2624 After Slight Pullback as Consolidation Persists Perpetua Resources Secures 29 Billion US Loan for Idaho Gold and Antimony Mine UL Q4 2010 Earnings EPS Beat Expectations Revenue Context and Stock Dip PepGen Inc PEPG Nears Support as Stock Slips Slightly CRBP Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Pipeline Advances VRRM Q1 2026 Earnings EPS Beats Estimates on Strong Execution Stock Slightly Higher Adient Q1 2026 Earnings Earnings Beat Drives Stock Higher Amid Mixed Operational Signals IIPR Q1 2026 Earnings EPS Misses Estimates Amid Persistent Cannabis Sector Headwinds EP Q3 2025 Earnings Loss Per Share Reported Amid Ongoing Industry Headwinds Under Armour Inc UAA Q1 2026 Earnings EPS Miss Clouds Start of Fiscal Year Despite Positive Revenue Trends Collegium Pharmaceutical Q1 2026 Earnings EPS Surpasses Estimates Amid Strategic Execution